Notification foe Retail price fixation of 30 new drug applications

REGD. No. D. L.-33004/99 The Gazette of India CG-DL-E-29052026-272936 EXTRAORDINARY PART II—Section 3—Sub-section (ii) PUBLISHED BY AUTHORITY No. 2587] NEW DELHI, WEDNESDAY, MAY 27, 2026/JYAISTHA 6, 1948 MINISTRY OF CHEMICALS AND FERTILIZERS (Department of Pharmaceuticals) (NATIONAL PHARMACEDUTICAL PRICING AUTHORITY) ORDER New Delhi, the 27th May, 2026 S.O. 2680(E).— In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S.O. 5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof; TABLE +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | SI. | Name of the | Strength | Unit | Manufacturer & Marketing | Retail | | No. | Formulation / Brand | | | Company | Price | | | Name | | | | (Rs.) | +=====+===================================+==================================================================================================+===========+=============================================================+==============+ | (1) | (2) | (3) | (4) | (5) | (6) | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 1 | Alginate Raft -Forming | Each 5 ml contains: | 1 ml | M/s Akums Drugs & Pharmaceuticals | 0.90 | | | Oral Suspension | Sodium Alginate IP 250 mg | | Ltd./M/s Blue Cross Laboratories Pvt. | | | | | Sodium Bicarbonate IP 133.5 mg | | Ltd. | | | | | Calcium Carbonate IP 80 mg | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 2 | Sodium Alginate, | Each 5 ml contains: | 1 ml | M/s Stedman Pharmaceuticals | 0.95 | | | Sodium Bicarbonate & | Sodium Alginate IP 250 mg | | Pvt. Ltd. | | | | Calcium Carbonate Oral | Sodium Bicarbonate IP 133.5 mg | | | | | | Liquid | Calcium Carbonate IP 80 mg | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 3 | Atorvastatin and | Each Film Coated Tablet | 1 Tablet | M/s Pure and Cure Healthcare | 18.46 | | | Fenofibrate | Contains: | | Pvt. Ltd./ | | | | Tablets | Atorvastatin Calcium IP | | M/s Alkem Wellness Ltd. | | | | | eq. to Atorvastatin 10 mg | | | | | | | Fenofibrate IP 160 mg | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 4 | Bilastine & Montelukast | Each Film Coated Bilayered | 1 Tablet | M/s Akums Drugs & Pharmaceuticals | 21.22 | | | Tablets | Tablet Contains: | | Ltd./M/s Aristo Pharmaceuticals | | | | | Bilastine IP 40 mg | | Pvt. Ltd. | | | | | Montelukast Sodium IP eq. to | | | | | | | Montelukast 10 mg | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 5 | Bisoprolol Fumarate and | Each film coated tablet contains: | 1 Tablet | M/s Swiss Garnier Life Sciences/ | 9.40 | | | Amlodipine Tablets | Bisoprolol Fumarate IP 5 mg | | M/s Ipca Laboratories Ltd. | | | | | Amlodipine Besylate IP eq. to | | | | | | | Amlodipine 5 mg | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 6 | Bisoprolol Fumarate and | Each Film Coated Tablet | 1 Tablet | M/s Swiss Garnier Life Sciences/ | 7.31 | | | Amlodipine Tablets | Contains: | | M/s Ipca Laboratories Ltd. | | | | | Bisoprolol Fumarate IP 2.5 mg | | | | | | | Amlodipine Besylate IP eq. to | | | | | | | Amlodipine 5 mg | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 7 | Calcium, Vitamin D3, | Each Film Coated Tablet | 1 Tablet | M/s Akums Drugs & Pharmaceuticals | 19.78 | | | Methylcobalamin, | Contains: | | Ltd./ M/s Sun Pharmaceutical | | | | L-Methylfolate Calcium | Calcium Carbonate IP 1250 mg | | Industries Ltd. | | | | & Pyridoxal-5 Phosphate | Eq. to Elemental Calcium 500 | | | | | | Tablets | mg | | | | | | | Vitamin D3 IP 2000 IU | | | | | | | Mecobalamin IP | | | | | | | (Methylcobalamin) 1500 mcg | | | | | | | L-Methylfolate Calcium 1 mg | | | | | | | Pyridoxal - 5 - Phosphate 20 mg | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 8 | Cefpodoxime and | Each Combipack Contains: | 1 ml | M/s Malik Lifesciences Pvt. Ltd./ | 3.65 | | | Potassium Clavulanate | 1.Cefpodoxime & Potassium | | M/s Blue Cross Laboratories Pvt. Ltd. | | | | Oral Suspension | Clavulanate Oral Suspension | | | | | | | Each 5 ml of constituted | | | | | | | suspension contains: | | | | | | | Cefpodoxime Proxetil IP Eq. to | | | | | | | Cefpodoxime 50 mg Potassium | | | | | | | Clavulanate Diluted IP Eq. to | | | | | | | Clavulanic Acid 31.25 mg | | | | | | | 2. Sterile Water for reconstitution | | | | | | | (Pyrogen free) 30ml | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 9 | Cefpodoxime and | Each Combipack Contains: 1. | 1 ml | M/s Malik Lifesciences Pvt. Ltd./ | 5.74 | | | Potassium Clavulanate | Cefpodoxime & Potassium | | M/s Blue Cross Laboratories Pvt. Ltd. | | | | Oral Suspension | Clavulanate Oral Suspension | | | | | | | Each 5 ml of constituted | | | | | | | suspension contains: | | | | | | | Cefpodoxime Proxetil IP Eq. to | | | | | | | Cefpodoxime 100mg Potassium | | | | | | | Clavulanate Diluted IP Eq. to | | | | | | | Clavulanic Acid 62.50 mg 2. | | | | | | | Sterile Water for reconstitution | | | | | | | (Pyrogen free) 30ml | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 10 | Vitamin D3 Oral Solution | Each 5 ml Contains: | 1 ml | M/s Tirupati Medicare Ltd./ | 14.91 | | | | Cholecalciferol IP 60000 IU | | M/s Intas Pharmaceuticals Ltd. | | | | | (In Nano | | | | | | | Droplet Form) | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 11 | Cholecalciferol Oral | Each 5ml contains: | 1 ml | M/s Pharma Synth Formulations Ltd. | 15.88 | | | Solution | Cholecalciferol IP 60000 IU | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 12 | Cilnidipine and | Each Film Coated Tablet | 1 Tablet | M/s Akums Drugs & Pharmaceuticals | 14.95 | | | Telmisartan Tablets | Contains: | | Ltd./ | | | | | Cilnidipine IP 20 mg | | M/s Alkem Laboratories Ltd. | | | | | Telmisartan IP 40 mg | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 13 | Cilnidipine and | Each Film Coated Tablet | 1 Tablet | M/s Pure and Cure Healthcare Pvt. | 12.98 | | | Telmisartan Tablets | Contains: | | Ltd./ | | | | | Cilnidipine IP 10 mg | | M/s Alkem Laboratories Ltd. | | | | | Telmisartan IP 40 mg | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 14 | Cilnidipine, Telmisartan | Each Film Coated Tablet | 1 Tablet | M/s Pure and Cure Healthcare Pvt. | 11.83 | | | & | Contains: Metoprolol Succinate | | Ltd./M/s Alkem Wellness Ltd. | | | | Metoprolol Succinate | IP 23.75 mg Eq. to Metoprolol | | | | | | (ER) Tablets | Tartrate 25 mg (As Extended | | | | | | | Release) | | | | | | | Cilnidipine IP 10 mg | | | | | | | Telmisartan IP 40 mg | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 15 | Cilnidipine, Telmisartan | Each Film Coated Tablet | 1 Tablet | M/s Pure and Cure Healthcare Pvt. | 14.80 | | | & | Contains: Metoprolol Succinate | | Ltd./M/s Alkem Wellness Ltd. | | | | Metoprolol Succinate | IP 47.50 mg Eq. to Metoprolol | | | | | | (ER) Tablets | Tartrate 50 mg (As Extended | | | | | | | Release) | | | | | | | Cilnidipine IP 10 mg | | | | | | | Telmisartan IP 40 mg | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 16 | Diclofenac | Composition: | 1 gm | M/s Theon Pharmaceuticals Ltd./ | 3.31 | | | Diethylamine, Linseed | Diclofenac Diethylamine IP | | M/s Jagsonpal Pharmaceuticals Ltd. | | | | Oil, Methyl Salicylate, | 1.16% w/w (eq. to Diclofenac | | | | | | Capsaicin & Menthol | Sodium 1% w/w) | | | | | | Gel | Linseed Oil BP 3% w/w | | | | | | | Methyl Salicylate IP 10% | | | | | | | w/wCapsaicin USP 0.025% w/w | | | | | | | Menthol IP 5% w/w | | | | | | | Benzyl Alcohol IP 1% w/w | | | | | | | (Preservative) | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 17 | Diclofenac Potassium, | Each film coated tablet contains: | 1 Tablet | M/s Innova Captab Ltd./ | 10.07 | | | Paracetamol & | Diclofenac Potassium BP 50 mg | | M/s Dr. Reddys Laboratories Ltd. | | | | Serratiopeptidase Tablets | Paracetamol IP 325 mg | | | | | | | Serratiopeptidase IP 10 mg | | | | | | | (As enteric coated granules Eq. | | | | | | | 20000 Serratiopeptidase Units) | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 18 | Dicyclomine | Each ml contains | 1 ml | M/s Nichepharm Lifesciences Pvt. | 10.05 | | | Hydrochloride & | Dicyclomine Hydrochloride IP | | Ltd./M/s Blue Cross Laboratories | | | | Diclofenac Sodium | 10 mg | | Pvt. Ltd. | | | | Injection | Diclofenac Sodium IP 25 mg | | | | | | | Benzyl Alcohol IP 4% v/v | | | | | | | (as preservative) | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 19 | Dicyclomine | Each ml contains: | 1 ml | M/s Fast Pharma Pvt. Ltd./ | 30.58 | | | Hydrochloride & | Dicyclomine Hydrochloride IP | | M/s German Remedies | | | | Diclofenac Sodium | 20 mg | | Pharmaceuticals Pvt. Ltd. | | | | Injection | Diclofenac Sodium IP 50 mg | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 20 | Empagliflozin, | Each film coated bilayer tablet | 1 Tablet | M/s Exemed Pharmaceuticals/ | 14.88 | | | Sitagliptin and | contains: | | M/s USV Pvt. Ltd. | | | | Metformin | Empagliflozin 10 mg | | | | | | Hydrochloride Extended | Metformin Hydrochloride (As | | | | | | Release Tablets | Extended Release) IP 1000 mg | | | | | | | Sitagliptin Phosphate | | | | | | | Monohydrate IP eq. to Sitagliptin | | | | | | | 100 mg | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 21 | Myo-Inositol, | Each 5g Sachet contains: | 1 gm | M/s Safetab Life Science/ | 9.52 | | | D-Chiro Inositol | Vitamin D3 (Stabilized form) | | M/s Mankind Pharma Ltd. | | | | and Vitamin D3 | 1000 IU | | | | | | Powder | Myo-Inositol IP 2000 mg | | | | | | | D-Chiro Inositol 50mg | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 22 | Norethisterone Acetate | Each Film Coated Controlled | 1 Tablet | M/s Akums Drugs & Pharmaceuticals | 20.11 | | | Controlled Release | Release Tablet contains: | | Ltd./M/s Zorvia Healthcare Ltd. | | | | Tablets | Norethisterone Acetate BP 15 | | | | | | | mg | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 23 | Norethisterone Acetate | Each Film Coated Controlled | 1 Tablet | M/s Akums Drugs & Pharmaceuticals | 18.40 | | | Controlled Release | Release Tablet contains: | | Ltd./M/s Zorvia Healthcare Ltd. | | | | Tablets | Norethisterone Acetate BP 10 mg | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 24 | Paracetamol, | Each uncoated tablet contains: | 1 Tablet | M/s East African (India) Overseas/ | 5.15 | | | Phenylephrine | Paracetamol IP 500mg | | M/s Macleods Pharmaceuticals Ltd. | | | | Hydrochloride and | Phenylephrine Hydrochloride IP | | | | | | Chlorpheniramine | 10mg | | | | | | Maleate Tablets | Chlorpheniramine Maleate IP | | | | | | | 2mg | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 25 | Sitagliptin, Glimepiride | Each film coated tablet contains: | 1 Tablet | M/s Exemed Pharmaceuticals/ | 11.91 | | | and Metformin | Sitagliptin Phosphate | | M/s Alkem Wellness Ltd. | | | | Hydrochloride Tablets | Monohydrate IP | | | | | | | eq. to Sitagliptin 50 mg | | | | | | | Glimepiride IP 2 mg | | | | | | | Metformin Hydrochloride IP 500 | | | | | | | mg | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 26 | Sitagliptin, Glimepiride | Each film coated tablet contains: | 1 Tablet | M/s Exemed Pharmaceuticals/ | 10.39 | | | and Metformin | Sitagliptin Phosphate | | M/s Alkem Wellness Ltd. | | | | Hydrochloride Tablets | Monohydrate IP | | | | | | | eq. to Sitagliptin 50 mg | | | | | | | Glimepiride IP 1 mg | | | | | | | Metformin Hydrochloride IP 500 | | | | | | | mg | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 27 | Teneligliptin and | Each Film Coated Tablet | 1 Tablet | M/s Pure and Cure Healthcare Pvt. | 10.17 | | | Dapagliflozin | Contains: | | Ltd./M/s Alkem Wellness Ltd. | | | | Tablets | Teneligliptin Hydrobromide | | | | | | | Hydrate IP | | | | | | | Eq. to Teneligliptin 20 mg | | | | | | | Dapagliflozin Propanediol USP | | | | | | | Eq. to Dapagliflozin 10 mg | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 28 | Trypsin-Chymotrypsin | Each film coated tablet contains: | 1 Tablet | M/s Synokem Pharmaceuticals Ltd./ | 13.02 | | | With Paracetamol and | 50,000 Armour Units Enzymatic | | M/s Troikaa Pharmaceuticals Ltd. | | | | Aceclofenac Tablets | Activity Supplied by a Purified | | | | | | | Concentrate which has Specific | | | | | | | Trypsin & Chymotrypsin Activity | | | | | | | in a Ratio of Approximately Six | | | | | | | to One (As enteric coated | | | | | | | granules) | | | | | | | Paracetamol IP 325 mg | | | | | | | Aceclofenac IP 100 mg | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 29 | Vildagliptin and | Each film coated tablet contains: | 1 Tablet | M/s Ved Lifesavers (P) Ltd./ | 9.79 | | | Metformin | Vildagliptin IP 50 mg | | M/s Alkem Wellness Ltd. | | | | Hydrochloride Tablets | Metformin Hydrochloride IP | | | | | | | 1000 mg | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ | 30 | Tacrolimus Prolonged | Each hard gelatin capsule | 1 Capsule | M/s Zydus Lifesciences Ltd. | 127.00 | | | Release Capsules | contains: | | | | | | | Tacrolimus IP 3 mg | | | | +-----+-----------------------------------+--------------------------------------------------------------------------------------------------+-----------+-------------------------------------------------------------+--------------+ Notes: (a) The manufacturer of above-mentioned formulations i.e., "new drug" under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove. (b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form-V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers. (d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies. (f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer & Marketing Companies as specified in corresponding entries in Column (2), (3) and (5) thereof, if any, issued prior to this notification, stand(s) superseded. [PN/278/146/2026/F/F. No. 8(146)/2026/D.P./NPPA-Div.-II] BHIVA RAM YADAV, Assistant Director Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064 and Published by the Controller of Publications, Delhi-110054.